117 related articles for article (PubMed ID: 23930696)
21. Bortezomib and panobinostat combination is effective against PTCL.
Phipps C; Mok SJ; Ang AL; Goh YT; Tan D
Leuk Res; 2012 Jun; 36(6):e128-30. PubMed ID: 22444688
[No Abstract] [Full Text] [Related]
22. [Treatment of transplant-eligible symptomatic multiple myeloma].
Nakaseko C
Rinsho Ketsueki; 2014 Oct; 55(10):2016-26. PubMed ID: 25297767
[No Abstract] [Full Text] [Related]
23. Intermediate-dose melphalan (100 mg/m2)/bortezomib/thalidomide/dexamethasone and stem cell support in patients with refractory or relapsed myeloma.
Palumbo A; Avonto I; Bruno B; Falcone A; Scalzulli PR; Ambrosini MT; Bringhen S; Gay F; Rus C; Cavallo F; Falco P; Massaia M; Musto P; Boccadoro M
Clin Lymphoma Myeloma; 2006 May; 6(6):475-7. PubMed ID: 16796778
[TBL] [Abstract][Full Text] [Related]
24. [Waldenström's macroglobulinemia].
Poulain S; Wemeau M; Balkaran S; Hivert B; Hautecoeur A; Rossignol J; Fernandez J; Daudignon A; Roumier C; Soenen V; Lepelley P; Lai JL; Morel P; Leleu X
Rev Med Interne; 2010 May; 31(5):385-94. PubMed ID: 20363537
[TBL] [Abstract][Full Text] [Related]
25. Induction bortezomib in Al amyloidosis followed by high dose melphalan and autologous stem cell transplantation: a single institution retrospective study.
Scott EC; Heitner SB; Dibb W; Meyers G; Smith SD; Abar F; Kovacsovics T; Perez-Avraham G; Stentz A; Frires R; Dibb J; Maziarz RT
Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):424-430.e1. PubMed ID: 24650974
[TBL] [Abstract][Full Text] [Related]
26. [Modern times: back to past, back to future].
Feliu J; Zabalza A; García-Muñoz R; Olavarría E
Med Clin (Barc); 2012 Jul; 139(4):180-1. PubMed ID: 22281094
[No Abstract] [Full Text] [Related]
27. Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients.
Silvennoinen R; Kairisto V; Pelliniemi TT; Putkonen M; Anttila P; Säily M; Sikiö A; Opas J; Penttilä K; Kuittinen T; Honkanen T; Lundán T; Juvonen V; Luukkaala T; Remes K
Br J Haematol; 2013 Feb; 160(4):561-4. PubMed ID: 23206270
[No Abstract] [Full Text] [Related]
28. Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma.
Wang M; Giralt S; Delasalle K; Handy B; Alexanian R
Hematology; 2007 Jun; 12(3):235-9. PubMed ID: 17558699
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of Bing-Neel syndrome using intrathecal chemotherapy and systemic combination chemotherapy followed by BEAM auto-transplant: a case report and review of literature.
Abdallah AO; Atrash S; Muzaffar J; Abdallah M; Kumar M; Van Rhee F; Barlogie B
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):502-6. PubMed ID: 23747080
[No Abstract] [Full Text] [Related]
30. Tandem transplants in the treatment of multiple myeloma. Pro.
Fassas AB; Tricot G
Clin Adv Hematol Oncol; 2004 May; 2(5):303-4. PubMed ID: 17682284
[No Abstract] [Full Text] [Related]
31. [Multiple myeloma].
Iida S
Rinsho Ketsueki; 2012 Feb; 53(2):155-63. PubMed ID: 22450574
[No Abstract] [Full Text] [Related]
32. Effective salvage treatment of recurrent Ewing sarcoma utilizing chemotherapy and zoledronic acid.
Siddiqui T; Marsh Rde W; Allegra C; Whittaker D; Scarborough M; Gibbs P; Zlotecki R; Reith JD; Drane W
Clin Adv Hematol Oncol; 2010 Jul; 8(7):499-504. PubMed ID: 20864918
[No Abstract] [Full Text] [Related]
33. [Case report; a case of acute kidney injury due to intravenous zoledronic acid hydrate, improved with bortezomib plus dexamethazone therapy in a patient with multiple myeloma].
Koike K; Morishige S; Fukami K; Taguchi K; Yakushiji K; Okamura T; Okuda S
Nihon Naika Gakkai Zasshi; 2011 Jan; 100(1):179-81. PubMed ID: 21387650
[No Abstract] [Full Text] [Related]
34. Myeloma presenting during pregnancy.
Smith D; Stevens J; Quinn J; Cavenagh J; Ingram W; Yong K
Hematol Oncol; 2014 Mar; 32(1):52-5. PubMed ID: 23996410
[No Abstract] [Full Text] [Related]
35. The role of serum immunoglobulin free light chain in response and progression in waldenstrom macroglobulinemia.
Leleu X; Xie W; Bagshaw M; Banwait R; Leduc R; Roper N; Weller E; Ghobrial IM
Clin Cancer Res; 2011 May; 17(9):3013-8. PubMed ID: 21415221
[TBL] [Abstract][Full Text] [Related]
36. Paget disease manifesting with compressive sixth-nerve palsy that resolved with intravenous zoledronic acid therapy.
Pane A
Arch Ophthalmol; 2007 Oct; 125(10):1440-1. PubMed ID: 17923566
[No Abstract] [Full Text] [Related]
37. The Medical Research Council Myeloma IX Trial: new clinical insights on the anticancer effects of zoledronic acid in patients with multiple myeloma.
Berenson JR
Clin Lymphoma Myeloma Leuk; 2012 Feb; 12(1):2-4. PubMed ID: 22130220
[No Abstract] [Full Text] [Related]
38. Percutaneous vertebroplasty combined with zoledronic acid for the treatment of painful osteolytic spinal metastases in patients with breast cancer.
Zhang J; Wang Y; Han K; Tang L; Hu H; Wu C; Shen Z; Sun Y; Yao Y
J Vasc Interv Radiol; 2013 Dec; 24(12):1861-7. PubMed ID: 24144536
[TBL] [Abstract][Full Text] [Related]
39. Complete remission of Waldenström macroglobulinemia with azacitidine and rituximab.
Weiss L; Melchardt T; Neureiter D; Kemmerling R; Moshir S; Pleyer L; Greil R; Egle A
J Clin Oncol; 2011 Aug; 29(24):e696-8. PubMed ID: 21730268
[No Abstract] [Full Text] [Related]
40. Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma.
Ramadan KM; McKenna KE; Morris TC
Lancet Oncol; 2006 Nov; 7(11):958-9. PubMed ID: 17081923
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]